Michael Boe Møller
Impact in
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 112
- Genetics 65
- Chronic Lymphocytic Leukemia Research 48
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16
- Co-authors
- Thomas Kielsgaard Kristensen (30 shared papers)Hanne Vestergaard (24 shared papers)Niels T. Pedersen (13 shared papers)Bjarne Egelund Christensen (9 shared papers)Ole Nielsen (7 shared papers)Sigurd Broesby‐Olsen (22 shared papers)Carsten Bindslev‐Jensen (19 shared papers)Hans Carl Hasselbalch (13 shared papers)
- Journals
- Blood (28 papers)European Journal Of Haematology (12 papers)Leukemia (9 papers)Modern Pathology (7 papers)Oncotarget (7 papers)
- Partner nations
- DenmarkUnited StatesItaly
In The Last Decade
Michael Boe Møller
221 papers receiving 8.4k citations
Michael Boe Møller's Hit Papers
Peers
Comparison fields: 5 of 149
- Pathology and Forensic Medicine 4.2k
- Genetics 2.2k
- Oncology 2.9k
- Immunology 1.7k
- Immunology and Allergy 410
Countries citing papers authored by Michael Boe Møller
This map shows the geographic impact of Michael Boe Møller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Boe Møller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Boe Møller more than expected).
Fields of papers citing papers by Michael Boe Møller
This network shows the impact of papers produced by Michael Boe Møller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Boe Møller. The network helps show where Michael Boe Møller may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Boe Møller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Hit paper breakdown → | 2012 | 569 |
| 2 | MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program Hit paper breakdown → | 2013 | 561 |
| 3 | 2012 | 326 | |
| 4 | 2011 | 308 | |
| 5 | 2012 | 291 | |
| 6 | 1999 | 222 | |
| 7 | 2003 | 211 | |
| 8 | 2013 | 198 | |
| 9 | 2011 | 173 | |
| 10 | 2008 | 165 | |
| 11 | 2014 | 162 | |
| 12 | 2012 | 138 | |
| 13 | 2007 | 130 | |
| 14 | 2012 | 127 | |
| 15 | 2014 | 126 | |
| 16 | 2019 | 117 | |
| 17 | 2017 | 116 | |
| 18 | 2013 | 114 | |
| 19 | 2014 | 107 | |
| 20 | 1994 | 106 |
About Michael Boe Møller
Michael Boe Møller is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Hematology, having authored 234 papers that have together received 8.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (112 papers), Chronic Lymphocytic Leukemia Research (48 papers), Viral-associated cancers and disorders (38 papers), Mast cells and histamine (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Acute Myeloid Leukemia Research (14 papers), CNS Lymphoma Diagnosis and Treatment (13 papers) and Eosinophilic Disorders and Syndromes (13 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.2k citations), Genetics (2.2k citations), Oncology (2.9k citations), Immunology (1.7k citations) and Immunology and Allergy (410 citations). Michael Boe Møller has collaborated with scholars based in Denmark, United States and Italy. Frequent co-authors include Thomas Kielsgaard Kristensen, Hanne Vestergaard, Niels T. Pedersen, Bjarne Egelund Christensen, Ole Nielsen, Sigurd Broesby‐Olsen, Carsten Bindslev‐Jensen, Hans Carl Hasselbalch, Ken H. Young and Thomas Stauffer Larsen. Their work appears in journals such as Blood, European Journal Of Haematology, Leukemia, Modern Pathology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.